News
Discover the latest progress in cancer research, education and clinical care delivered by the MPCCC.
.jpg)
MPCCC shares precision oncology and lived experience leadership at COSA 2026
MPCCC’s work to improve access to precision oncology and strengthen lived experience leadership featured at the 2026 Clinical Oncology Society of Australia (COSA) Annual Scientific Meeting.
Across three days, the meeting brought together the cancer sector to share research and approaches to care under the theme, “The precision generation: From cancer prevention to personalised care”, a focus closely aligned with MPCCC’s work across Victoria.
MPCCC’s Evelyn Loh presented on behalf of Lama Karroum and the team in the Best of the Best Rapid Fire Orals: Clinical research & Precision care session. Her presentation, “Evaluating a Consortium-Based Molecular Tumour Board: Improving Access to Precision Oncology Across Metropolitan and Regional Victoria”, highlighted MPCCC’s collaborative approach to precision oncology. ASN Events
The presentation explored how MPCCC’s Molecular Tumour Board is building workforce capability and helping bridge gaps in access to genomic expertise across metropolitan and regional Victoria. By connecting health professionals across services, the program supports shared learning and helps clinicians use complex genomic information to inform cancer care.
MPCCC’s contribution also extended to lived experience leadership, with the Lived Experience Leadership Program selected for a poster presentation. This recognition reflects the importance of supporting people affected by cancer to contribute their expertise and help shape research and care.
The meeting offered valuable opportunities to learn from colleagues, exchange ideas and build connections across the sector. The MPCCC team returned with fresh insights to inform its ongoing work in genomics, workforce development and care delivery, with equitable access remaining central to these efforts.
